Autologous chimeric antigen receptor (CAR)-T cells, targeting B cell CD19 and inducing deep depletion of B cells, were tested in a few patients with SSc, leading to improvement of skin score, arthritis, digital ulcers, and inflammatory changes in heart and lungs. This evidence concerns the gene CD19 and arthritic joint disease.